Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV)infection, and adaptation is greatest in HBV e Antigen-Negative Disease

Journal of Virology

Volumn 86, Issue 2, 2012, Pages 1181-1192

  Desmond, Christopher P ^a,b   Gaudieri, Silvana ^c,d   James, Ian R ^c   Pfafferott, Katja ^c   Chopra, Abha ^c   Lau, George K ^e   Audsley, Jennifer ^b   Day, Caroline ^f   Chivers, Sarah ^f   Gordon, Adam ^a,f   Revill, Peter A ^g   Bowden, Scott ^g   Ayres, Anna ^g   Desmond, Paul V ^h,i   Thompson, Alexander J ^g,h   Roberts, Stuart K ^a   Locarnini, Stephen A ^g   Mallal, Simon A ^c,j   Lewinb, Sharon R ^k,l  

^a The Alfred ^*  (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MURDOCH UNIVERSITY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f BOX HILL HOSPITAL   (Australia)

^g VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^h ST VINCENT S HOSPITAL   (Australia)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j ROYAL PERTH HOSPITAL   (Australia)

^k Infectious Diseases Unit   (Australia)

^l BURNET INSTITUTE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ADAPTATION; ANTIGEN BINDING; ARTICLE; ASIAN; AUSTRALIA; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HLA TYPING; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; T LYMPHOCYTE; VIRAL ADAPTATION; VIRUS GENOME;

ADAPTATION, BIOLOGICAL; AMINO ACID SEQUENCE; AUSTRALIA; CHINA; EPITOPES, T-LYMPHOCYTE; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HLA ANTIGENS; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES;

HEPATITIS B VIRUS;

EID: 84856860373     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05308-11     Document Type: Article

References (49)

1. Abbott WG, et al. 2010. Associations between HLA class I alleles and escape mutations in the hepatitis B virus core gene in New Zealandresident Tongans. J. Virol. 84:621-629.
2. Bertoletti A, et al. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407-410.
3. Bhattacharya T, et al. 2007. Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science 315:1583-1586.
4. Bozkaya H, Ayola B, Lok AS. 1996. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection. Hepatology 24:32-37.
5. Carman WF, et al. 1997. Hepatitis B virus core protein mutations are concentrated in B cell epitopes in progressive disease and in T helper cell epitopes during clinical remission. J. Infect. Dis. 175:1093-1100.
6. Chen BF, et al. 2006. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130:1153-1168.
7. Chisari FV, Ferrari C. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29-60.
8. Desmond CP, Bartholomeusz A, Gaudieri S, Revill PA, Lewin SR. 2008. A systematic review of T-cell epitopes in hepatitis B virus: identification, genotypic variation and relevance to antiviral therapeutics. Antivir. Ther. 13:161-175.
9. Dienstag J. 2008. Hepatitis B virus infection. N. Engl. J. Med. 359: 1486-1500.
10. Fares MA, Holmes EC. 2002. A revised evolutionary history of hepatitis B virus (HBV). J. Mol. Evol. 54:807-814.
11. Ferrari C, et al. 1990. Cellular immune response to hepatitis B virusencoded antigens in acute and chronic hepatitis B virus infection. J. Immunol. 145:3442-3449.
12. Gaudieri S, et al. 2006. Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection. J. Virol. 80:11094-11104.
13. Guidotti LG, et al. 1996. The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice. J. Virol. 70:7056-7061.
14. Günther S, et al. 1995. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J. Virol. 69: 5437-5444.
15. Hannoun C, Horal P, Lindh M. 2000. Long-term mutation rates in the hepatitis B virus genome. J. Gen. Virol. 81:75-83.
16. Kawashima Y, et al. 2009. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458:641-645.
17. Krausa P, Browning MJ. 1996. HLA-A2 polymorphism and immune functions. Eur. J. Immunogenet. 23:261-274.
18. Lee HG, et al. 1997. Peptide-specific CTL induction in HBV-seropositive PBMC by stimulation with peptides in vitro: novel epitopes identified from chronic carriers. Virus Res. 50:185-194.
19. Lee WM. 1997. Hepatitis B virus infection. N. Engl. J. Med. 337:1733-1745.
20. Leslie A, et al. 2005. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA. J. Exp. Med. 201:891-902.
21. Lewin SR, et al. 2001. Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed. Hepatology 34: 1012-1020.
22. Liu HG, et al. 2008. A mutant HBs antigen (HBsAg)183-191 epitope elicits specific cytotoxic T lymphocytes in acute hepatitis B patients. Clin. Exp. Immunol. 151:441-447.
23. Maini MK, et al. 2000. T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection. Eur. J. Immunol. 30:3067-3078.
24. Merican I, et al. 2000. Chronic hepatitis B virus infection in Asian countries. J. Gastroenterol. Hepatol. 15:1356-1361.
25. Middleton D, Menchaca L, Rood H, Komerofsky R. 2003. New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens 61: 403-407.
26. Milich D, Liang TJ. 2003. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38:1075-1086.
27. Milich DR, Chen MK, Hughes JL, Jones JE. 1998. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J. Immunol. 160:2013-2021.
28. Mizokami M, et al. 1997. Constrained evolution with respect to gene overlap of hepatitis B virus. J. Mol. Evol. 44(Suppl. 1):S83-S90.
29. Moore CB, et al. 2002. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296:1439-1443.
30. Nowak MA, et al. 1996. Viral dynamics in hepatitis B virus infection. Proc. Natl. Acad. Sci. U. S. A. 93:4398-4402.
31. Okazaki T, et al. 2006. Possible therapeutic vaccine strategy against human immunodeficiency virus escape from reverse transcriptase inhibitors studied in HLA-A2 transgenic mice. J. Virol. 80:10645-10651.
32. Orito E, et al. 1989. Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences. Proc. Natl. Acad. Sci. U. S. A. 86:7059-7062.
33. Osiowy C, Giles E, Tanaka Y, Mizokami M, Minuk GY. 2006. Molecular evolution of hepatitis B virus over 25 years. J. Virol. 80:10307-10314.
34. Parker KC, Bednarek MA, Coligan JE. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152:163-175.
35. Rammensee H, Bachman J, Emmerich N, Bachor O, Stevanovic S. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213-219.
36. Rauch A, et al. 2009. Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure. Hepatology 50:1017-1029.
37. Rehermann B, et al. 1995. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181:1047-1058.
38. Rehermann B, Pasquinelli C, Mosier SM, Chisari FV. 1995. Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronicHBVinfection. J. Clin. Invest. 96:1527-1534.
39. Riedl P, et al. 2006. Distinct, cross-reactive epitope specificities of CD8 T cell responses are induced by natural hepatitis B surface antigen variants of different hepatitis B virus genotypes. J. Immunol. 176:4003-4011.
40. Riordan SM, Skinner N, Kurtovic J, Locarnini S, Visvanathan K. 2006. Reduced expression of toll-like receptor 2 on peripheral monocytes in patients with chronic hepatitis B. Clin. Vaccine Immunol. 13:972-974.
41. Rossol S, et al. 1997. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J. Clin. Invest. 99:3025-3033.
42. Sette A, et al. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153: 5586-5592.
43. Sobao Y, et al. 2001. Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*2402, the most common HLA class I allele in East Asia. J. Hepatol. 34:922-929.
44. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596-1599.
45. Timm J, et al. 2007. Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution. Hepatology 46:339-349.
46. Visvanathan K, et al. 2007. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 45:102-110.
47. Wang P, et al. 2008. A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput. Biol. 4:e1000048.
48. Witt CS, et al. 2002. Common HLA-B8-DR3 haplotype in Northern India is different from that found in Europe. Tissue Antigens 60:474-480.
49. Zhang J, Rosenberg HF, Nei M. 1998. Positive Darwinian selection after gene duplication in primate ribonuclease genes. Proc. Natl. Acad. Sci. U. S. A. 95:3708-3713.